nodes	percent_of_prediction	percent_of_DWPC	metapath
Heptabarbital—GRIK2—cerebellar cortex—malignant glioma	0.114	0.134	CbGeAlD
Heptabarbital—GRIK2—telencephalic ventricle—malignant glioma	0.0663	0.0777	CbGeAlD
Heptabarbital—CHRNA4—telencephalic ventricle—malignant glioma	0.0533	0.0624	CbGeAlD
Heptabarbital—GRIA2—embryo—malignant glioma	0.0217	0.0254	CbGeAlD
Heptabarbital—GRIA2—brainstem—malignant glioma	0.0199	0.0233	CbGeAlD
Heptabarbital—GABRA6—brainstem—malignant glioma	0.0192	0.0225	CbGeAlD
Heptabarbital—GRIK2—brainstem—malignant glioma	0.0179	0.021	CbGeAlD
Heptabarbital—GRIA2—telencephalon—malignant glioma	0.0176	0.0206	CbGeAlD
Heptabarbital—GRIK2—retina—malignant glioma	0.0173	0.0203	CbGeAlD
Heptabarbital—GABRA6—telencephalon—malignant glioma	0.017	0.02	CbGeAlD
Heptabarbital—GABRA5—telencephalon—malignant glioma	0.0165	0.0194	CbGeAlD
Heptabarbital—CHRFAM7A—telencephalon—malignant glioma	0.0161	0.0188	CbGeAlD
Heptabarbital—GRIK2—telencephalon—malignant glioma	0.0159	0.0187	CbGeAlD
Heptabarbital—GABRA4—telencephalon—malignant glioma	0.015	0.0176	CbGeAlD
Heptabarbital—CHRNA4—brainstem—malignant glioma	0.0144	0.0169	CbGeAlD
Heptabarbital—CHRNA7—retina—malignant glioma	0.0141	0.0165	CbGeAlD
Heptabarbital—CHRNA7—telencephalon—malignant glioma	0.013	0.0152	CbGeAlD
Heptabarbital—GABRA2—brainstem—malignant glioma	0.0129	0.0151	CbGeAlD
Heptabarbital—CHRNA4—telencephalon—malignant glioma	0.0128	0.015	CbGeAlD
Heptabarbital—GRIA2—midbrain—malignant glioma	0.0127	0.0148	CbGeAlD
Heptabarbital—GRIK2—medulla oblongata—malignant glioma	0.0125	0.0147	CbGeAlD
Heptabarbital—GABRA1—brainstem—malignant glioma	0.0125	0.0146	CbGeAlD
Heptabarbital—GRIA2—spinal cord—malignant glioma	0.0123	0.0145	CbGeAlD
Heptabarbital—GABRA2—telencephalon—malignant glioma	0.0115	0.0134	CbGeAlD
Heptabarbital—GRIK2—midbrain—malignant glioma	0.0114	0.0134	CbGeAlD
Heptabarbital—GRIK2—spinal cord—malignant glioma	0.0112	0.0131	CbGeAlD
Heptabarbital—GABRA1—telencephalon—malignant glioma	0.0111	0.013	CbGeAlD
Heptabarbital—GRIA2—central nervous system—malignant glioma	0.01	0.0117	CbGeAlD
Heptabarbital—Hexobarbital—PTGS1—malignant glioma	0.00999	0.434	CrCbGaD
Heptabarbital—GRIA2—cerebellum—malignant glioma	0.00979	0.0115	CbGeAlD
Heptabarbital—GABRA6—central nervous system—malignant glioma	0.00968	0.0113	CbGeAlD
Heptabarbital—GABRA6—cerebellum—malignant glioma	0.00946	0.0111	CbGeAlD
Heptabarbital—GABRA5—central nervous system—malignant glioma	0.00939	0.011	CbGeAlD
Heptabarbital—CHRNA4—midbrain—malignant glioma	0.00919	0.0108	CbGeAlD
Heptabarbital—CHRFAM7A—central nervous system—malignant glioma	0.00913	0.0107	CbGeAlD
Heptabarbital—GRIK2—central nervous system—malignant glioma	0.00905	0.0106	CbGeAlD
Heptabarbital—CHRNA4—spinal cord—malignant glioma	0.00896	0.0105	CbGeAlD
Heptabarbital—GRIK2—cerebellum—malignant glioma	0.00884	0.0104	CbGeAlD
Heptabarbital—GABRA3—central nervous system—malignant glioma	0.00874	0.0102	CbGeAlD
Heptabarbital—GABRA1—medulla oblongata—malignant glioma	0.0087	0.0102	CbGeAlD
Heptabarbital—GABRA4—central nervous system—malignant glioma	0.00852	0.00998	CbGeAlD
Heptabarbital—GABRA4—cerebellum—malignant glioma	0.00832	0.00975	CbGeAlD
Heptabarbital—GRIA2—brain—malignant glioma	0.00795	0.00932	CbGeAlD
Heptabarbital—GABRA1—midbrain—malignant glioma	0.00795	0.00931	CbGeAlD
Heptabarbital—GABRA1—spinal cord—malignant glioma	0.00775	0.00909	CbGeAlD
Heptabarbital—GABRA6—brain—malignant glioma	0.00768	0.009	CbGeAlD
Heptabarbital—Phenobarbital—CYP2C18—malignant glioma	0.00748	0.325	CrCbGaD
Heptabarbital—GABRA5—brain—malignant glioma	0.00745	0.00873	CbGeAlD
Heptabarbital—CHRNA7—central nervous system—malignant glioma	0.00737	0.00864	CbGeAlD
Heptabarbital—CHRNA4—central nervous system—malignant glioma	0.00727	0.00852	CbGeAlD
Heptabarbital—CHRFAM7A—brain—malignant glioma	0.00725	0.00849	CbGeAlD
Heptabarbital—GRIK2—brain—malignant glioma	0.00718	0.00842	CbGeAlD
Heptabarbital—CHRNA4—cerebellum—malignant glioma	0.00711	0.00833	CbGeAlD
Heptabarbital—GABRA3—brain—malignant glioma	0.00694	0.00813	CbGeAlD
Heptabarbital—GABRA4—brain—malignant glioma	0.00676	0.00792	CbGeAlD
Heptabarbital—GABRA2—central nervous system—malignant glioma	0.00651	0.00763	CbGeAlD
Heptabarbital—GABRA2—cerebellum—malignant glioma	0.00636	0.00745	CbGeAlD
Heptabarbital—GABRA1—central nervous system—malignant glioma	0.00629	0.00737	CbGeAlD
Heptabarbital—GABRA1—cerebellum—malignant glioma	0.00615	0.0072	CbGeAlD
Heptabarbital—CHRNA7—brain—malignant glioma	0.00585	0.00686	CbGeAlD
Heptabarbital—CHRNA4—brain—malignant glioma	0.00577	0.00676	CbGeAlD
Heptabarbital—Phenobarbital—CYP2B6—malignant glioma	0.00555	0.241	CrCbGaD
Heptabarbital—GABRA2—brain—malignant glioma	0.00517	0.00606	CbGeAlD
Heptabarbital—GABRA1—brain—malignant glioma	0.00499	0.00585	CbGeAlD
Heptabarbital—GABRA1—Orphan transporters—COX8A—malignant glioma	0.0017	0.0138	CbGpPWpGaD
Heptabarbital—GABRA5—Orphan transporters—APOD—malignant glioma	0.00161	0.013	CbGpPWpGaD
Heptabarbital—GABRA3—Orphan transporters—APOD—malignant glioma	0.00158	0.0128	CbGpPWpGaD
Heptabarbital—GABRA2—Orphan transporters—APOD—malignant glioma	0.00155	0.0125	CbGpPWpGaD
Heptabarbital—GRIA2—N-cadherin signaling events—FGFR1—malignant glioma	0.00153	0.0124	CbGpPWpGaD
Heptabarbital—CHRNA7—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.00133	0.0108	CbGpPWpGaD
Heptabarbital—GABRA1—Orphan transporters—APOD—malignant glioma	0.00132	0.0107	CbGpPWpGaD
Heptabarbital—GABRA6—Ion channel transport—ATP1B2—malignant glioma	0.00132	0.0107	CbGpPWpGaD
Heptabarbital—GRIA2—N-cadherin signaling events—PTPN11—malignant glioma	0.00131	0.0106	CbGpPWpGaD
Heptabarbital—GABRA4—Ion channel transport—ATP1B2—malignant glioma	0.0013	0.0105	CbGpPWpGaD
Heptabarbital—CHRNA7—SIDS Susceptibility Pathways—MYB—malignant glioma	0.00123	0.00996	CbGpPWpGaD
Heptabarbital—GRIA2—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—MDM2—malignant glioma	0.00121	0.0098	CbGpPWpGaD
Heptabarbital—CHRNA7—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.00119	0.00962	CbGpPWpGaD
Heptabarbital—GABRA5—Ion channel transport—ATP1B2—malignant glioma	0.00116	0.00937	CbGpPWpGaD
Heptabarbital—GABRA3—Ion channel transport—ATP1B2—malignant glioma	0.00114	0.0092	CbGpPWpGaD
Heptabarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—malignant glioma	0.00113	0.00911	CbGpPWpGaD
Heptabarbital—GABRA2—Ion channel transport—ATP1B2—malignant glioma	0.00112	0.00905	CbGpPWpGaD
Heptabarbital—CHRNA4—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.00109	0.0088	CbGpPWpGaD
Heptabarbital—CHRNA4—SIDS Susceptibility Pathways—MYB—malignant glioma	0.001	0.00812	CbGpPWpGaD
Heptabarbital—CHRNA4—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.000969	0.00784	CbGpPWpGaD
Heptabarbital—GABRA1—Ion channel transport—ATP1B2—malignant glioma	0.000953	0.00771	CbGpPWpGaD
Heptabarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—RAF1—malignant glioma	0.00094	0.00761	CbGpPWpGaD
Heptabarbital—CHRNA7—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.000925	0.00748	CbGpPWpGaD
Heptabarbital—CHRNA7—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.000925	0.00748	CbGpPWpGaD
Heptabarbital—GRIA2—BDNF signaling pathway—NTRK2—malignant glioma	0.000829	0.00671	CbGpPWpGaD
Heptabarbital—GRIK2—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000812	0.00657	CbGpPWpGaD
Heptabarbital—GRIK2—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000763	0.00618	CbGpPWpGaD
Heptabarbital—CHRNA7—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.00076	0.00615	CbGpPWpGaD
Heptabarbital—CHRNA4—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.000754	0.0061	CbGpPWpGaD
Heptabarbital—CHRNA4—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.000754	0.0061	CbGpPWpGaD
Heptabarbital—CHRNA7—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000739	0.00598	CbGpPWpGaD
Heptabarbital—CHRNA7—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000694	0.00562	CbGpPWpGaD
Heptabarbital—GRIA2—BDNF signaling pathway—NTRK1—malignant glioma	0.000675	0.00547	CbGpPWpGaD
Heptabarbital—GABRA1—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.000673	0.00545	CbGpPWpGaD
Heptabarbital—CHRNA7—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000663	0.00536	CbGpPWpGaD
Heptabarbital—GRIK2—Neuronal System—BCHE—malignant glioma	0.000622	0.00503	CbGpPWpGaD
Heptabarbital—GABRA1—SIDS Susceptibility Pathways—MYB—malignant glioma	0.000621	0.00503	CbGpPWpGaD
Heptabarbital—GRIA2—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000621	0.00502	CbGpPWpGaD
Heptabarbital—GRIA2—N-cadherin signaling events—PIK3CA—malignant glioma	0.000621	0.00502	CbGpPWpGaD
Heptabarbital—CHRNA4—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.000619	0.00501	CbGpPWpGaD
Heptabarbital—CHRNA4—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000602	0.00487	CbGpPWpGaD
Heptabarbital—GABRA1—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.0006	0.00486	CbGpPWpGaD
Heptabarbital—GRIK2—Neuronal System—SLC6A3—malignant glioma	0.000585	0.00473	CbGpPWpGaD
Heptabarbital—GRIA2—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000584	0.00472	CbGpPWpGaD
Heptabarbital—GABRA6—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000575	0.00465	CbGpPWpGaD
Heptabarbital—GABRA4—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000567	0.00459	CbGpPWpGaD
Heptabarbital—CHRNA4—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000566	0.00458	CbGpPWpGaD
Heptabarbital—CHRNA7—Neuronal System—BCHE—malignant glioma	0.000566	0.00458	CbGpPWpGaD
Heptabarbital—CHRNA7—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000555	0.00449	CbGpPWpGaD
Heptabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000551	0.00446	CbGpPWpGaD
Heptabarbital—GRIA2—BDNF signaling pathway—SPP1—malignant glioma	0.000549	0.00444	CbGpPWpGaD
Heptabarbital—CHRNA4—SIDS Susceptibility Pathways—HES1—malignant glioma	0.00054	0.00437	CbGpPWpGaD
Heptabarbital—CHRNA7—Neuronal System—SLC6A3—malignant glioma	0.000532	0.00431	CbGpPWpGaD
Heptabarbital—GABRA6—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000526	0.00425	CbGpPWpGaD
Heptabarbital—GABRA4—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000519	0.0042	CbGpPWpGaD
Heptabarbital—GABRA6—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000516	0.00418	CbGpPWpGaD
Heptabarbital—GABRA4—Transmission across Chemical Synapses—BCHE—malignant glioma	0.00051	0.00413	CbGpPWpGaD
Heptabarbital—GABRA5—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000504	0.00408	CbGpPWpGaD
Heptabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000501	0.00406	CbGpPWpGaD
Heptabarbital—GABRA3—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000495	0.00401	CbGpPWpGaD
Heptabarbital—GABRA2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000487	0.00394	CbGpPWpGaD
Heptabarbital—GABRA6—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000485	0.00393	CbGpPWpGaD
Heptabarbital—GABRA4—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000479	0.00388	CbGpPWpGaD
Heptabarbital—GRIA2—Neuronal System—BCHE—malignant glioma	0.000476	0.00385	CbGpPWpGaD
Heptabarbital—GABRA1—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.000467	0.00378	CbGpPWpGaD
Heptabarbital—GABRA1—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.000467	0.00378	CbGpPWpGaD
Heptabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000462	0.00374	CbGpPWpGaD
Heptabarbital—CHRNA4—Neuronal System—BCHE—malignant glioma	0.000461	0.00373	CbGpPWpGaD
Heptabarbital—GABRA5—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000461	0.00373	CbGpPWpGaD
Heptabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.00046	0.00372	CbGpPWpGaD
Heptabarbital—GABRA6—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000459	0.00372	CbGpPWpGaD
Heptabarbital—GABRA4—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000454	0.00367	CbGpPWpGaD
Heptabarbital—GABRA5—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000453	0.00367	CbGpPWpGaD
Heptabarbital—GABRA3—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000453	0.00367	CbGpPWpGaD
Heptabarbital—CHRNA4—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000453	0.00366	CbGpPWpGaD
Heptabarbital—GRIA2—BDNF signaling pathway—BAD—malignant glioma	0.000453	0.00366	CbGpPWpGaD
Heptabarbital—GRIA2—Neuronal System—SLC6A3—malignant glioma	0.000447	0.00362	CbGpPWpGaD
Heptabarbital—GABRA6—Transmembrane transport of small molecules—APOD—malignant glioma	0.000447	0.00362	CbGpPWpGaD
Heptabarbital—GABRA2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000445	0.0036	CbGpPWpGaD
Heptabarbital—GABRA3—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000445	0.0036	CbGpPWpGaD
Heptabarbital—GABRA4—Transmembrane transport of small molecules—APOD—malignant glioma	0.000441	0.00357	CbGpPWpGaD
Heptabarbital—GRIA2—BDNF signaling pathway—APC—malignant glioma	0.000438	0.00355	CbGpPWpGaD
Heptabarbital—GABRA2—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000437	0.00354	CbGpPWpGaD
Heptabarbital—CHRNA4—Neuronal System—SLC6A3—malignant glioma	0.000434	0.00351	CbGpPWpGaD
Heptabarbital—GRIA2—BDNF signaling pathway—PTPN11—malignant glioma	0.000431	0.00349	CbGpPWpGaD
Heptabarbital—GABRA5—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000426	0.00345	CbGpPWpGaD
Heptabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000421	0.00341	CbGpPWpGaD
Heptabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.00042	0.0034	CbGpPWpGaD
Heptabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000419	0.00339	CbGpPWpGaD
Heptabarbital—GABRA3—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000418	0.00339	CbGpPWpGaD
Heptabarbital—GABRA1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000415	0.00336	CbGpPWpGaD
Heptabarbital—GRIK2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000414	0.00335	CbGpPWpGaD
Heptabarbital—GABRA2—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000411	0.00333	CbGpPWpGaD
Heptabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000409	0.00331	CbGpPWpGaD
Heptabarbital—GABRA5—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000403	0.00326	CbGpPWpGaD
Heptabarbital—GABRA3—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000396	0.0032	CbGpPWpGaD
Heptabarbital—GABRA6—Neuronal System—BCHE—malignant glioma	0.000396	0.0032	CbGpPWpGaD
Heptabarbital—GABRA5—Transmembrane transport of small molecules—APOD—malignant glioma	0.000392	0.00317	CbGpPWpGaD
Heptabarbital—GABRA4—Neuronal System—BCHE—malignant glioma	0.000391	0.00316	CbGpPWpGaD
Heptabarbital—GABRA2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000389	0.00315	CbGpPWpGaD
Heptabarbital—GABRA3—Transmembrane transport of small molecules—APOD—malignant glioma	0.000385	0.00312	CbGpPWpGaD
Heptabarbital—GABRA1—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.000384	0.0031	CbGpPWpGaD
Heptabarbital—GABRA1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00038	0.00307	CbGpPWpGaD
Heptabarbital—GABRA2—Transmembrane transport of small molecules—APOD—malignant glioma	0.000378	0.00306	CbGpPWpGaD
Heptabarbital—CHRNA7—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000377	0.00305	CbGpPWpGaD
Heptabarbital—GABRA1—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000373	0.00302	CbGpPWpGaD
Heptabarbital—GABRA6—Neuronal System—SLC6A3—malignant glioma	0.000372	0.00301	CbGpPWpGaD
Heptabarbital—GABRA4—Neuronal System—SLC6A3—malignant glioma	0.000367	0.00297	CbGpPWpGaD
Heptabarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.00036	0.00292	CbGpPWpGaD
Heptabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000353	0.00286	CbGpPWpGaD
Heptabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000352	0.00285	CbGpPWpGaD
Heptabarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000351	0.00284	CbGpPWpGaD
Heptabarbital—GABRA1—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.00035	0.00284	CbGpPWpGaD
Heptabarbital—GRIK2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000347	0.00281	CbGpPWpGaD
Heptabarbital—GABRA5—Neuronal System—BCHE—malignant glioma	0.000347	0.00281	CbGpPWpGaD
Heptabarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000346	0.0028	CbGpPWpGaD
Heptabarbital—GRIK2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000346	0.0028	CbGpPWpGaD
Heptabarbital—CHRNA7—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000346	0.0028	CbGpPWpGaD
Heptabarbital—CHRNA7—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000345	0.00279	CbGpPWpGaD
Heptabarbital—GRIA2—BDNF signaling pathway—RAF1—malignant glioma	0.000344	0.00278	CbGpPWpGaD
Heptabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000342	0.00277	CbGpPWpGaD
Heptabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000341	0.00276	CbGpPWpGaD
Heptabarbital—GABRA3—Neuronal System—BCHE—malignant glioma	0.000341	0.00276	CbGpPWpGaD
Heptabarbital—GABRA2—Neuronal System—BCHE—malignant glioma	0.000335	0.00271	CbGpPWpGaD
Heptabarbital—GABRA1—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000334	0.00271	CbGpPWpGaD
Heptabarbital—GABRA1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000332	0.00268	CbGpPWpGaD
Heptabarbital—GABRA5—Neuronal System—SLC6A3—malignant glioma	0.000326	0.00264	CbGpPWpGaD
Heptabarbital—GABRA1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000323	0.00261	CbGpPWpGaD
Heptabarbital—GABRA3—Neuronal System—SLC6A3—malignant glioma	0.00032	0.00259	CbGpPWpGaD
Heptabarbital—GRIK2—Neuronal System—BRAF—malignant glioma	0.000317	0.00257	CbGpPWpGaD
Heptabarbital—GRIA2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000317	0.00256	CbGpPWpGaD
Heptabarbital—CHRNA7—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000316	0.00256	CbGpPWpGaD
Heptabarbital—GABRA2—Neuronal System—SLC6A3—malignant glioma	0.000315	0.00255	CbGpPWpGaD
Heptabarbital—CHRNA7—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000315	0.00255	CbGpPWpGaD
Heptabarbital—GRIA2—BDNF signaling pathway—CASP3—malignant glioma	0.000309	0.0025	CbGpPWpGaD
Heptabarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000308	0.00249	CbGpPWpGaD
Heptabarbital—CHRNA4—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000307	0.00249	CbGpPWpGaD
Heptabarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000302	0.00244	CbGpPWpGaD
Heptabarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000297	0.0024	CbGpPWpGaD
Heptabarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000294	0.00238	CbGpPWpGaD
Heptabarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000294	0.00238	CbGpPWpGaD
Heptabarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000293	0.00237	CbGpPWpGaD
Heptabarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000293	0.00237	CbGpPWpGaD
Heptabarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.00029	0.00235	CbGpPWpGaD
Heptabarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000289	0.00234	CbGpPWpGaD
Heptabarbital—CHRNA7—Neuronal System—BRAF—malignant glioma	0.000289	0.00234	CbGpPWpGaD
Heptabarbital—GABRA1—Neuronal System—BCHE—malignant glioma	0.000286	0.00231	CbGpPWpGaD
Heptabarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000282	0.00228	CbGpPWpGaD
Heptabarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000281	0.00227	CbGpPWpGaD
Heptabarbital—GABRA1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.00028	0.00227	CbGpPWpGaD
Heptabarbital—GABRA1—Neuronal System—SLC6A3—malignant glioma	0.000269	0.00217	CbGpPWpGaD
Heptabarbital—GRIK2—Neuronal System—MDM2—malignant glioma	0.000266	0.00215	CbGpPWpGaD
Heptabarbital—GRIA2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000265	0.00215	CbGpPWpGaD
Heptabarbital—GRIK2—Neuronal System—RAF1—malignant glioma	0.000265	0.00215	CbGpPWpGaD
Heptabarbital—GRIA2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000265	0.00214	CbGpPWpGaD
Heptabarbital—GABRA6—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000264	0.00213	CbGpPWpGaD
Heptabarbital—GABRA6—Ion channel transport—RAF1—malignant glioma	0.00026	0.00211	CbGpPWpGaD
Heptabarbital—GABRA4—Transmission across Chemical Synapses—BRAF—malignant glioma	0.00026	0.00211	CbGpPWpGaD
Heptabarbital—GRIA2—BDNF signaling pathway—STAT3—malignant glioma	0.00026	0.0021	CbGpPWpGaD
Heptabarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000258	0.00209	CbGpPWpGaD
Heptabarbital—CHRNA4—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000257	0.00208	CbGpPWpGaD
Heptabarbital—GABRA4—Ion channel transport—RAF1—malignant glioma	0.000257	0.00208	CbGpPWpGaD
Heptabarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000257	0.00208	CbGpPWpGaD
Heptabarbital—CHRNA4—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000257	0.00208	CbGpPWpGaD
Heptabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000253	0.00205	CbGpPWpGaD
Heptabarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000253	0.00205	CbGpPWpGaD
Heptabarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000252	0.00204	CbGpPWpGaD
Heptabarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000251	0.00203	CbGpPWpGaD
Heptabarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000249	0.00201	CbGpPWpGaD
Heptabarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000248	0.00201	CbGpPWpGaD
Heptabarbital—GRIA2—Neuronal System—BRAF—malignant glioma	0.000243	0.00196	CbGpPWpGaD
Heptabarbital—CHRNA7—Neuronal System—MDM2—malignant glioma	0.000242	0.00196	CbGpPWpGaD
Heptabarbital—CHRNA7—Neuronal System—RAF1—malignant glioma	0.000241	0.00195	CbGpPWpGaD
Heptabarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000239	0.00193	CbGpPWpGaD
Heptabarbital—CHRNA4—Neuronal System—BRAF—malignant glioma	0.000235	0.00191	CbGpPWpGaD
Heptabarbital—GABRA5—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000231	0.00187	CbGpPWpGaD
Heptabarbital—GABRA6—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000229	0.00185	CbGpPWpGaD
Heptabarbital—GABRA5—Ion channel transport—RAF1—malignant glioma	0.000228	0.00185	CbGpPWpGaD
Heptabarbital—GABRA3—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000227	0.00184	CbGpPWpGaD
Heptabarbital—GABRA4—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000226	0.00183	CbGpPWpGaD
Heptabarbital—GABRA3—Ion channel transport—RAF1—malignant glioma	0.000224	0.00182	CbGpPWpGaD
Heptabarbital—GABRA2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000223	0.00181	CbGpPWpGaD
Heptabarbital—GABRA6—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000221	0.00179	CbGpPWpGaD
Heptabarbital—GABRA2—Ion channel transport—RAF1—malignant glioma	0.00022	0.00178	CbGpPWpGaD
Heptabarbital—GABRA6—Transmission across Chemical Synapses—RAF1—malignant glioma	0.00022	0.00178	CbGpPWpGaD
Heptabarbital—GABRA4—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000218	0.00176	CbGpPWpGaD
Heptabarbital—GABRA4—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000217	0.00176	CbGpPWpGaD
Heptabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000212	0.00172	CbGpPWpGaD
Heptabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000211	0.00171	CbGpPWpGaD
Heptabarbital—GABRA6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00021	0.0017	CbGpPWpGaD
Heptabarbital—GABRA4—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000207	0.00168	CbGpPWpGaD
Heptabarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000204	0.00165	CbGpPWpGaD
Heptabarbital—GRIA2—Neuronal System—MDM2—malignant glioma	0.000203	0.00165	CbGpPWpGaD
Heptabarbital—GRIA2—Neuronal System—RAF1—malignant glioma	0.000203	0.00164	CbGpPWpGaD
Heptabarbital—GABRA6—Neuronal System—BRAF—malignant glioma	0.000202	0.00163	CbGpPWpGaD
Heptabarbital—GABRA5—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000201	0.00162	CbGpPWpGaD
Heptabarbital—GABRA6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.0002	0.00162	CbGpPWpGaD
Heptabarbital—GABRA4—Neuronal System—BRAF—malignant glioma	0.000199	0.00161	CbGpPWpGaD
Heptabarbital—GABRA4—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000197	0.0016	CbGpPWpGaD
Heptabarbital—CHRNA4—Neuronal System—MDM2—malignant glioma	0.000197	0.0016	CbGpPWpGaD
Heptabarbital—GABRA3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000197	0.0016	CbGpPWpGaD
Heptabarbital—CHRNA4—Neuronal System—RAF1—malignant glioma	0.000197	0.00159	CbGpPWpGaD
Heptabarbital—GABRA2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000194	0.00157	CbGpPWpGaD
Heptabarbital—GABRA5—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000194	0.00157	CbGpPWpGaD
Heptabarbital—GABRA5—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000193	0.00156	CbGpPWpGaD
Heptabarbital—GABRA1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.00019	0.00154	CbGpPWpGaD
Heptabarbital—GABRA3—Transmission across Chemical Synapses—MDM2—malignant glioma	0.00019	0.00154	CbGpPWpGaD
Heptabarbital—GABRA3—Transmission across Chemical Synapses—RAF1—malignant glioma	0.00019	0.00153	CbGpPWpGaD
Heptabarbital—GABRA1—Ion channel transport—RAF1—malignant glioma	0.000188	0.00152	CbGpPWpGaD
Heptabarbital—GABRA2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000187	0.00151	CbGpPWpGaD
Heptabarbital—GABRA2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000186	0.00151	CbGpPWpGaD
Heptabarbital—GABRA5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000184	0.00149	CbGpPWpGaD
Heptabarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000182	0.00147	CbGpPWpGaD
Heptabarbital—GABRA3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000181	0.00147	CbGpPWpGaD
Heptabarbital—GABRA2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000178	0.00144	CbGpPWpGaD
Heptabarbital—GABRA5—Neuronal System—BRAF—malignant glioma	0.000177	0.00143	CbGpPWpGaD
Heptabarbital—GABRA5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000175	0.00142	CbGpPWpGaD
Heptabarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000174	0.00141	CbGpPWpGaD
Heptabarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000174	0.00141	CbGpPWpGaD
Heptabarbital—GABRA3—Neuronal System—BRAF—malignant glioma	0.000174	0.00141	CbGpPWpGaD
Heptabarbital—GABRA3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000172	0.00139	CbGpPWpGaD
Heptabarbital—GABRA2—Neuronal System—BRAF—malignant glioma	0.000171	0.00138	CbGpPWpGaD
Heptabarbital—GABRA2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000169	0.00137	CbGpPWpGaD
Heptabarbital—GABRA6—Neuronal System—MDM2—malignant glioma	0.000169	0.00137	CbGpPWpGaD
Heptabarbital—GABRA6—Neuronal System—RAF1—malignant glioma	0.000169	0.00136	CbGpPWpGaD
Heptabarbital—GRIA2—BDNF signaling pathway—AKT1—malignant glioma	0.000167	0.00135	CbGpPWpGaD
Heptabarbital—GABRA4—Neuronal System—MDM2—malignant glioma	0.000167	0.00135	CbGpPWpGaD
Heptabarbital—GABRA4—Neuronal System—RAF1—malignant glioma	0.000166	0.00135	CbGpPWpGaD
Heptabarbital—GABRA1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000165	0.00134	CbGpPWpGaD
Heptabarbital—GABRA1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000159	0.00129	CbGpPWpGaD
Heptabarbital—GABRA1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000159	0.00129	CbGpPWpGaD
Heptabarbital—GABRA1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000152	0.00123	CbGpPWpGaD
Heptabarbital—GABRA5—Neuronal System—MDM2—malignant glioma	0.000148	0.0012	CbGpPWpGaD
Heptabarbital—GABRA5—Neuronal System—RAF1—malignant glioma	0.000148	0.0012	CbGpPWpGaD
Heptabarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000148	0.0012	CbGpPWpGaD
Heptabarbital—GABRA1—Neuronal System—BRAF—malignant glioma	0.000146	0.00118	CbGpPWpGaD
Heptabarbital—GABRA3—Neuronal System—MDM2—malignant glioma	0.000146	0.00118	CbGpPWpGaD
Heptabarbital—GABRA3—Neuronal System—RAF1—malignant glioma	0.000145	0.00118	CbGpPWpGaD
Heptabarbital—GABRA1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000144	0.00117	CbGpPWpGaD
Heptabarbital—GABRA2—Neuronal System—MDM2—malignant glioma	0.000143	0.00116	CbGpPWpGaD
Heptabarbital—GABRA2—Neuronal System—RAF1—malignant glioma	0.000143	0.00116	CbGpPWpGaD
Heptabarbital—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000127	0.00102	CbGpPWpGaD
Heptabarbital—GABRA1—Neuronal System—MDM2—malignant glioma	0.000122	0.000988	CbGpPWpGaD
Heptabarbital—GABRA1—Neuronal System—RAF1—malignant glioma	0.000122	0.000985	CbGpPWpGaD
Heptabarbital—GABRA6—Transmembrane transport of small molecules—RAF1—malignant glioma	9.06e-05	0.000734	CbGpPWpGaD
Heptabarbital—GABRA4—Transmembrane transport of small molecules—RAF1—malignant glioma	8.95e-05	0.000724	CbGpPWpGaD
Heptabarbital—GABRA5—Transmembrane transport of small molecules—RAF1—malignant glioma	7.95e-05	0.000644	CbGpPWpGaD
Heptabarbital—GABRA3—Transmembrane transport of small molecules—RAF1—malignant glioma	7.81e-05	0.000632	CbGpPWpGaD
Heptabarbital—GABRA2—Transmembrane transport of small molecules—RAF1—malignant glioma	7.67e-05	0.000621	CbGpPWpGaD
Heptabarbital—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.54e-05	0.00053	CbGpPWpGaD
